Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel insights into histone lysine methyltransferases in cancer therapy: From epigenetic regulation to selective drugs
Qi-Li Liao, Jie Yang, Shengfang Ge, et al.
Journal of Pharmaceutical Analysis (2022) Vol. 13, Iss. 2, pp. 127-141
Open Access | Times Cited: 20

Showing 20 citing articles:

Anticancer benzimidazole derivatives as inhibitors of epigenetic targets: a review article
Nardin Wagih, Islam M. Abdel-Rahman, Nawal El‐Koussi, et al.
RSC Advances (2025) Vol. 15, Iss. 2, pp. 966-1010
Open Access | Times Cited: 2
SETDB1: Progress and prospects in cancer treatment potential and inhibitor research
Tingnan Ma, Feifei Xu, Yingying Hou, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107219-107219
Closed Access | Times Cited: 5
Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer
Linxiang Zhang, Xueying Zhang, Yanbin Shi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Precision epigenetic editing: Technological advances, enduring challenges, and therapeutic applications
Goldie V. Roth, Isabella R. Gengaro, Lei S. Qi
Cell chemical biology (2024) Vol. 31, Iss. 8, pp. 1422-1446
Closed Access | Times Cited: 4
Histone demethylases in autophagy and inflammation
Yaoyao Ma, Wenting Lv, Yi Guo, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Immunohistochemical Profiling of Histone Modification Biomarkers Identifies Subtype-Specific Epigenetic Signatures and Potential Drug Targets in Breast Cancer
Zirong Huo, Sitong Zhang, Guodong Su, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 770-770
Open Access
The Contribution and Perspectives of Proteomics to Epithelial Ovarian Cancer
Junrui Pei, Haifeng Qiu, Wenjia Wang, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2025)
Closed Access
Identification of candidate genes and SNPs associated with growth traits by genome-wide association study (GWAS) in sea cucumber (Apostichopus japonicus)
Wei Cui, Fang Su, Shilin Liu, et al.
Aquaculture (2025), pp. 742512-742512
Closed Access
Epigenetic Therapy in Cervical Cancer
Anmi Jose, P. Shenoy, Yagya Malik, et al.
(2025), pp. 153-185
Closed Access
DNA methylation of HOX genes and its clinical implications in cancer
Xin Hu, Yong Wang, Xiaoyu Zhang, et al.
Experimental and Molecular Pathology (2023) Vol. 134, pp. 104871-104871
Open Access | Times Cited: 9
A Review of Advanced Cutaneous Melanoma Therapies and Their Mechanisms, from Immunotherapies to Lysine Histone Methyl Transferase Inhibitors
Renato Santos de Oliveira Filho, Daniel Arcuschin de Oliveira, Melissa Maeda Nisimoto, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5751-5751
Open Access | Times Cited: 9
Tumor-suppressive functions of protein lysine methyltransferases
Nur Aziz, Yo Han Hong, Han Gyung Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 12, pp. 2475-2497
Open Access | Times Cited: 5
A Review for Advanced Cutaneous Melanoma Therapies and Their Mechanisms, from Immunotherapies to Lysine Histone Methyl Transferase Inhibitors
Renato SO Filho, Daniel A Oliveira, Melissa Maeda Nisimoto, et al.
(2023)
Open Access | Times Cited: 2
Epigenetic Alterations as an Adaptive Response to Chemotherapy
Rubiada, Kaneez Fatima, Iqra Mushtaq, et al.
(2024), pp. 215-241
Closed Access
Inhibition of pseudo-allergic reactions by vitamin K3 directly targeting GAB1 in mast cells
Mengyang Ma, Zhuoyin Xue, Chenjia Li, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112490-112490
Closed Access
Nuclear translocation of ISG15 regulated by PPP2R2B inhibits cisplatin resistance of bladder cancer
Gaowei Huang, Jinwen Liu, Anze Yu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access
Genetic dysregulation of EP300 in cancers in light of cancer epigenome control – perspectives of specific targeting of p300 proficient and deficient cancers
Karolina Gronkowska, Agnieszka Robaszkiewicz
Deleted Journal (2024) Vol. 32, Iss. 4, pp. 200871-200871
Closed Access
Therapeutic targeting potential of the protein lysine and arginine methyltransferases to reverse cancer chemoresistance
Isaac Micallef, Kimberly Fenech, Byron Baron
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Immunohistochemical Profiling of Histone Modification Biomarkers Identifies Subtype-Specific Epigenetic Signatures and Potential Drug Targets in Breast Cancer
Zirong Huo, Sitong Zhang, Guodong Su, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Targeting the chromatin structural changes of antitumor immunity
Nian-nian Li, Deng‐xing Lun, Ningning Gong, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 14, Iss. 4, pp. 100905-100905
Open Access
Inhibition of methylation and notch receptors in cutaneous melanoma
Daniel Arcuschin de Oliveira, Cláudio Porta Fernandes, Paula Carolina Dias Machado, et al.
Seven Editora eBooks (2023)
Open Access
Page 1

Scroll to top